Table 1.
Comparison of quality of life European Organization for Research and Treatment of Cancer quality of life tool C-30 Global Health Status within and between control group and experimental group of breast cancer patients undergoing chemotherapy
| Chemotherapy cycles and number of patients in the control and experimental groups | Global health status | |||
|---|---|---|---|---|
| Mean±SD Median (minimum-maximum) | Difference (95% CI) | P* Mann-Whitney Test | ||
| Control group | Experimental group | |||
| Cycle I (n=100) | 64.26±7.62 66.66 (50-83.33) | 66.14±9.16 66.66 (50-83.33) | −1.88 (−5.21-1.45) | 0.263 |
| Control=52 | ||||
| Experiment=48 | ||||
| Cycle II (n=98) | 59.96±10.93 58.33# (33.33-83.33) | 65.78±12.79 66.66 (33.33-100) | −5.81 (−10.57-−1.05) | 0.0306** |
| Control=51 | ||||
| Experiment=47 | ||||
| Cycle III (n=96) | 58.66±11.65 58.33# (33.33-83.33) | 62.86±8.90 58.33# (33.33-83.33) | −4.19 (−8.42-0.036) | 0.0362** |
| Control=50 | ||||
| Experiment=46 | ||||
| Cycle IV (n=93) | 56.38±14.13 50# (33.33-100) | 65.21±10.58 66.66 (41.66-83.33) | −8.83 (−13.98-−3.68) | 0.0003** |
| Control=47 | ||||
| Experiment=46 | ||||
| Cycle V (n=84) | 56.74±11.38 54.16# (33.33-83.33) | 68.45±10.65 66.66 (33.33-83.33) | −11.70 (−16.49-−6.91) | 0.0000** |
| Control=42 | ||||
| Experiment=42 | ||||
| Cycle VI (n=83) | 59.32±13.04 58.33# (25-83.33) | 69.10±15.05 66.66 (0-83.33) | −9.78 (−15.92-−3.63) | 0.0001** |
| Control=42 | ||||
| Experiment=41 | ||||
| P value Friedman test | <0.0001 | <0.0001 | ||
*P<0.05, **Significant, #Wilcoxon signed-rank test (significant). SD: Standard deviation, CI: Confidence interval